Navigating commercial gaps to supercharge the UK life sciences sector
For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.
For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?